These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 756881)

  • 1. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
    Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A
    J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet.
    Pedrinelli R; Magagna A; Salvetti A
    Eur J Clin Invest; 1982 Apr; 12(2):107-11. PubMed ID: 6807681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of clonidine on renin and aldosterone of hypertensive patients.
    Salvetti A; Pedrinelli R; Cavasinni L; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):50-6. PubMed ID: 6989768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
    Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M
    Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension.
    Farsang C; Juhász I; Kapocsi J; Vajda L; Székács B
    Cardiology; 1981; 67(3):164-71. PubMed ID: 7023672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prostaglandin E1 on renin and aldosterone in hypertensive patients.
    Yoshimura M; Takahashi H; Takashina R; Kajita Y; Miyazaki T; Hachiya T; Ijichi H; Ochi Y
    Endocrinol Jpn; 1979 Aug; 26(4):481-6. PubMed ID: 499089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
    Kutyrina IM; Androsova SO; Warshavskii VA; Tareyeva IE
    Nephron; 1982; 32(3):244-8. PubMed ID: 6759952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
    Hata S
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
    Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
    Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
    Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
    G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone Levels, Aortic Stiffness, and Wave Reflection in Essential Hypertensive Patients.
    Tzamou V; Kyvelou SM; Karpanou E; Petras D; Vyssoulis G
    Am J Hypertens; 2015 Jul; 28(7):852-7. PubMed ID: 25542624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and the renin-aldosterone system.
    Noth RH; Lassman MN; Tan SY; Fernandez-Cruz A; Mulrow PJ
    Arch Intern Med; 1977 Oct; 137(10):1414-7. PubMed ID: 921422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of plasma renin activity in human renovascular hypertension.
    Salvetti A; Arzilli F; Sassano P; Poli L; Pesola A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():239s-242s. PubMed ID: 1071617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.